SCHEMBL1922607

SCHEMBL1922607

Cc1nn2c(-c3ccc(Cl)cc3Cl)c(C)oc2c1C=O.Cc1nn2c(-c3ccc(Cl)cc3Cl)c(C)oc2c1O

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 7/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NR2F2 P24468 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ CRHR1 P34998 5/20 0.34
▸ DPP8 Q6V1X1 1/20 0.34
▸ ABCB1 P08183 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1922267 0.93 DPP4 (0.40) DPP4SMN1; SMN2MAPTNR2F2HTT
SCHEMBL1922300 0.90 DPP4 (0.42) DPP4CYP2C9CYP2C19NPC1CRHR1
SCHEMBL1922983 0.79 CRHR1 (0.40) DPP4CYP2C9CYP2C19CRHR1DPP8
SCHEMBL1922981 0.79 CRHR1 (0.40) DPP4CYP2C9CYP2C19CRHR1DPP8
SCHEMBL1922979 0.77 LMNA (0.40) DPP4NPC1CRHR1DPP8CNR1
SCHEMBL1922297 0.77 LMNA (0.48) DPP4MAPTHTTCYP2C9CYP2C19
SCHEMBL1922992 0.76 DPP4 (0.42) DPP4CYP2C9CYP2C19NPC1CRHR1
SCHEMBL1922301 0.76 DPP4 (0.44) DPP4CYP2C9CYP2C19CRHR1DPP8
SCHEMBL1922431 0.74 DPP4 (0.39) DPP4CYP2C9CYP2C19NPC1CRHR1
SCHEMBL1922564 0.73 HSD11B1 (0.41) DPP4MAPTCRHR1DPP8HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328902-A1 PYRAZOLO [5,1-B]OXAZOLE DERIVATIVES AS CRF1 ANTAGONISTS Novartis AG (CH) 2011-06-08 — — EP disclosed
WO-2010015628-A1 PYRAZOLO [5,1-B] OXAZOLE DERIVATIVES AS CRF1 ANTAGONISTS NOVARTIS AG (CH) 2010-02-11 — — WO disclosed
Send feedback